vs
Side-by-side financial comparison of Organon & Co. (OGN) and MARRIOTT VACATIONS WORLDWIDE Corp (VAC). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.2B, roughly 1.2× MARRIOTT VACATIONS WORLDWIDE Corp). Organon & Co. runs the higher net margin — -13.6% vs -35.0%, a 21.4% gap on every dollar of revenue. On growth, MARRIOTT VACATIONS WORLDWIDE Corp posted the faster year-over-year revenue change (-0.7% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $-6.0M). Over the past eight quarters, MARRIOTT VACATIONS WORLDWIDE Corp's revenue compounded faster (5.2% CAGR vs -3.6%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
Marriott Vacations Worldwide Corporation is a pure-play public timeshare company. Formerly a division of Marriott International, Marriott Vacations Worldwide was established as a separate, publicly traded entity focusing primarily on vacation ownership in November 2011. Marriott Vacations Worldwide runs more than 120 resorts with over 700,000 Owners and members in a diverse portfolio of brands under The Marriott Vacation Clubs name. Its brands include Marriott Vacation Club, The Marriott Vaca...
OGN vs VAC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.2B |
| Net Profit | $-205.0M | $-431.0M |
| Gross Margin | 49.2% | — |
| Operating Margin | -9.8% | — |
| Net Margin | -13.6% | -35.0% |
| Revenue YoY | -5.3% | -0.7% |
| Net Profit YoY | -288.1% | -962.0% |
| EPS (diluted) | $-0.78 | $-12.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.6B | $1.2B | ||
| Q2 25 | $1.6B | $1.2B | ||
| Q1 25 | $1.5B | $1.1B | ||
| Q4 24 | $1.6B | $1.2B | ||
| Q3 24 | $1.6B | $1.2B | ||
| Q2 24 | $1.6B | $1.1B | ||
| Q1 24 | $1.6B | $1.1B |
| Q4 25 | $-205.0M | $-431.0M | ||
| Q3 25 | $160.0M | $-2.0M | ||
| Q2 25 | $145.0M | $69.0M | ||
| Q1 25 | $87.0M | $56.0M | ||
| Q4 24 | $109.0M | $50.0M | ||
| Q3 24 | $359.0M | $84.0M | ||
| Q2 24 | $195.0M | $37.0M | ||
| Q1 24 | $201.0M | $47.0M |
| Q4 25 | 49.2% | — | ||
| Q3 25 | 53.5% | — | ||
| Q2 25 | 54.8% | — | ||
| Q1 25 | 55.6% | — | ||
| Q4 24 | 56.3% | — | ||
| Q3 24 | 58.3% | — | ||
| Q2 24 | 58.4% | — | ||
| Q1 24 | 59.0% | — |
| Q4 25 | -9.8% | — | ||
| Q3 25 | 15.2% | — | ||
| Q2 25 | 14.4% | — | ||
| Q1 25 | 6.7% | — | ||
| Q4 24 | 8.1% | — | ||
| Q3 24 | 13.1% | — | ||
| Q2 24 | 14.6% | — | ||
| Q1 24 | 14.5% | — |
| Q4 25 | -13.6% | -35.0% | ||
| Q3 25 | 10.0% | -0.2% | ||
| Q2 25 | 9.1% | 6.0% | ||
| Q1 25 | 5.8% | 5.0% | ||
| Q4 24 | 6.8% | 4.0% | ||
| Q3 24 | 22.7% | 6.9% | ||
| Q2 24 | 12.1% | 3.5% | ||
| Q1 24 | 12.4% | 4.2% |
| Q4 25 | $-0.78 | $-12.00 | ||
| Q3 25 | $0.61 | $-0.07 | ||
| Q2 25 | $0.56 | $1.77 | ||
| Q1 25 | $0.33 | $1.46 | ||
| Q4 24 | $0.42 | $1.29 | ||
| Q3 24 | $1.38 | $2.12 | ||
| Q2 24 | $0.75 | $0.98 | ||
| Q1 24 | $0.78 | $1.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $406.0M |
| Total DebtLower is stronger | $8.6B | — |
| Stockholders' EquityBook value | $752.0M | $2.0B |
| Total Assets | $12.9B | $9.8B |
| Debt / EquityLower = less leverage | 11.49× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $574.0M | $406.0M | ||
| Q3 25 | $672.0M | $474.0M | ||
| Q2 25 | $599.0M | $205.0M | ||
| Q1 25 | $547.0M | $196.0M | ||
| Q4 24 | $675.0M | $197.0M | ||
| Q3 24 | $763.0M | $197.0M | ||
| Q2 24 | $704.0M | $206.0M | ||
| Q1 24 | $575.0M | $237.0M |
| Q4 25 | $8.6B | — | ||
| Q3 25 | $8.8B | — | ||
| Q2 25 | $8.9B | — | ||
| Q1 25 | $9.0B | — | ||
| Q4 24 | $8.9B | — | ||
| Q3 24 | $8.7B | — | ||
| Q2 24 | $8.7B | — | ||
| Q1 24 | $8.7B | — |
| Q4 25 | $752.0M | $2.0B | ||
| Q3 25 | $906.0M | $2.5B | ||
| Q2 25 | $733.0M | $2.5B | ||
| Q1 25 | $542.0M | $2.4B | ||
| Q4 24 | $472.0M | $2.4B | ||
| Q3 24 | $493.0M | $2.4B | ||
| Q2 24 | $144.0M | $2.4B | ||
| Q1 24 | $48.0M | $2.4B |
| Q4 25 | $12.9B | $9.8B | ||
| Q3 25 | $13.6B | $10.1B | ||
| Q2 25 | $13.5B | $9.9B | ||
| Q1 25 | $13.2B | $9.9B | ||
| Q4 24 | $13.1B | $9.8B | ||
| Q3 24 | $12.8B | $9.7B | ||
| Q2 24 | $12.2B | $9.6B | ||
| Q1 24 | $11.9B | $9.9B |
| Q4 25 | 11.49× | — | ||
| Q3 25 | 9.74× | — | ||
| Q2 25 | 12.14× | — | ||
| Q1 25 | 16.52× | — | ||
| Q4 24 | 18.81× | — | ||
| Q3 24 | 17.75× | — | ||
| Q2 24 | 60.11× | — | ||
| Q1 24 | 181.54× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | $6.0M |
| Free Cash FlowOCF − Capex | $96.0M | $-6.0M |
| FCF MarginFCF / Revenue | 6.4% | -0.5% |
| Capex IntensityCapex / Revenue | 3.0% | 1.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | $-29.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.0M | $6.0M | ||
| Q3 25 | $264.0M | $62.0M | ||
| Q2 25 | $220.0M | $-48.0M | ||
| Q1 25 | $75.0M | $8.0M | ||
| Q4 24 | $390.0M | $100.0M | ||
| Q3 24 | $141.0M | $72.0M | ||
| Q2 24 | $332.0M | $30.0M | ||
| Q1 24 | $76.0M | $3.0M |
| Q4 25 | $96.0M | $-6.0M | ||
| Q3 25 | $218.0M | $51.0M | ||
| Q2 25 | $181.0M | $-68.0M | ||
| Q1 25 | $43.0M | $-6.0M | ||
| Q4 24 | $335.0M | $86.0M | ||
| Q3 24 | $99.0M | $58.0M | ||
| Q2 24 | $300.0M | $17.0M | ||
| Q1 24 | $30.0M | $-13.0M |
| Q4 25 | 6.4% | -0.5% | ||
| Q3 25 | 13.6% | 4.3% | ||
| Q2 25 | 11.4% | -5.9% | ||
| Q1 25 | 2.8% | -0.5% | ||
| Q4 24 | 21.0% | 6.9% | ||
| Q3 24 | 6.3% | 4.8% | ||
| Q2 24 | 18.7% | 1.6% | ||
| Q1 24 | 1.8% | -1.2% |
| Q4 25 | 3.0% | 1.0% | ||
| Q3 25 | 2.9% | 0.9% | ||
| Q2 25 | 2.4% | 1.7% | ||
| Q1 25 | 2.1% | 1.3% | ||
| Q4 24 | 3.5% | 1.1% | ||
| Q3 24 | 2.7% | 1.1% | ||
| Q2 24 | 2.0% | 1.2% | ||
| Q1 24 | 2.8% | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | 1.65× | — | ||
| Q2 25 | 1.52× | -0.70× | ||
| Q1 25 | 0.86× | 0.14× | ||
| Q4 24 | 3.58× | 2.00× | ||
| Q3 24 | 0.39× | 0.86× | ||
| Q2 24 | 1.70× | 0.81× | ||
| Q1 24 | 0.38× | 0.06× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OGN
Segment breakdown not available.
VAC
| Cost Reimbursement | $467.0M | 38% |
| Time Share | $381.0M | 31% |
| Management And Exchange | $212.0M | 17% |
| Ancillary Revenues | $64.0M | 5% |
| Management Service | $55.0M | 4% |
| Service Other | $36.0M | 3% |
